Ionis Pharmaceuticals (IONS) EBITDA Margin Growth (3y) (2012 - 2026)
Ionis Pharmaceuticals (IONS) EBITDA Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ionis Pharmaceuticals | 9.21 Bn | 7.29 Bn | 243.11 Mn | 3,974.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,974.00 |
| Dec 31, 2025 | 3,148.00 |
| Sep 30, 2025 | -6,518.00 |
| Jun 30, 2025 | 705,472.00 |
| Mar 31, 2025 | -7,107.00 |
| Dec 31, 2024 | -9,905.00 |
| Sep 30, 2024 | -4,659.00 |
| Jun 30, 2024 | 2,869.00 |
| Mar 31, 2024 | -4,271.00 |
| Dec 31, 2023 | 5,312.00 |
| Sep 30, 2023 | -7,652.00 |
| Jun 30, 2023 | 35,024.00 |
| Mar 31, 2023 | -4,162.00 |
| Dec 31, 2022 | -71,618.00 |
| Sep 30, 2022 | -4,712.00 |
| Jun 30, 2022 | 24,987.00 |
| Mar 31, 2022 | -12,154.00 |
| Dec 31, 2021 | -1,148.00 |
| Sep 30, 2021 | 12,122.00 |
| Jun 30, 2021 | -1,532.00 |